Eschbach Sites a New Headquarters in Boston for the Rapidly Growing Pharmaceutical Sector

CW News Desk

April 28, 2019

Eschbach Sites a New Headquarters in Boston in a Bid to Cater to the Rapidly Growing Pharmaceutical Sector The new team in Boston has its Focus on fostering Expansion in Canada and the United States Eschbach, a Global software developer, providing digital manufacturing solutions to the pharmaceutical, food and chemical manufacturing sectors made an announcement today that it now has a base in North America. This new business unit, Eschbach North America, Inc., has its headquarters in Boston, Massachusetts. This is one of the most important focal points for high-tech companies all around the globe. Having a vibrant tech and biotech base, Boston acts as a strategic location and a source of a considerable pool of talent. With the base in U.S, the company will now have the ability to meet the growing demand in North America for its Industry 4.0 solutions. This reach is especially important for the chemical and pharmaceutical markets. "Our U.S. business has experienced tremendous growth recently. The location fits perfectly with our corporate culture and our goal to be in close proximity to customers in the United States and Canada." said Andreas Eschbach, CEO of eschbach. He is also set to manage the business worldwide from Boston.

Eschbach, a Global software developer, providing digital manufacturing solutions to the pharmaceutical, food and chemical manufacturing sectors made an announcement today that it now has a base in North America.

This new business unit, Eschbach North America, Inc., has its headquarters in Boston, Massachusetts. This is one of the most important focal points for high-tech companies all around the globe. Having a vibrant tech and biotech base, Boston acts as a strategic location and a source of a considerable pool of talent.

With the base in U.S, the company will now have the ability to meet the growing demand in North America for its Industry 4.0 solutions. This reach is especially important for the chemical and pharmaceutical markets.

“Our U.S. business has experienced tremendous growth recently. The location fits perfectly with our corporate culture and our goal to be in close proximity to customers in the United States and Canada.” said Andreas Eschbach, CEO of eschbach. He is also set to manage the business worldwide from Boston.

The company made an announcement of its new hire, Dennis Ladd. He was hired as the Senior Sales Consultant based in the Boston location.

“North America is an extremely important market for eschbach with regard to the chemical and pharmaceutical industry. In addition, it’s a great place to win first-class customers and partners as well as attract top talent to the company.” said Ladd.

Eschbach has grown to be prominent since 2005 when it was founded in Bad Säckingen, Germany. Within close proximity to the Swiss pharmaceutical metropolis of Basel, Eschbach has garnered more than 13 years. It has served leading companies such as Bayer, DuPont, Covestro, Royal DSM and Sanofi. This track record is an assurance that indeed, they are set to deliver again in Boston.

“With io.Performance OEE, we offer our users a visually appealing solution that evaluates plant-related information, reduces costs and guarantees maximum transparency. We are already very active in the U.S. with both solutions and strategic initiatives to convince many more companies of this,” explained Ladd.

An experienced team of experts has already arrived in Boston. “We have been able to recruit highly qualified colleagues in the USA. Our team consists of experienced sales experts and consultants so that we can competently accompany the entire implementation process of customers from the USA and Canada.” Ladd assured.